Clinical Trial

Selenium Supplementation for Improving Depression in Children and Adolescents: Efficacy and Mechanistic Study

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to investigate the role and mechanisms of selenium in depression among children and adolescents, aiming to provide new insights for understanding the pathogenesis and treatment of depression in this population.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-24; most recent amendment 2025-12-21.
Trial Details
NCT Number NCT07203144
Lead Sponsor First Affiliated Hospital of Chongqing Medical University
Conditions Depression - Major Depressive Disorder
Enrollment 172 participants
Start Date 2025-12-31
Primary Completion 2027-04-01 (estimated)
Study Completion 2027-04-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-29